Evidence map›Paper›PMID 28001094›Full record

Observational studySubstance use & misuse2017

Prevalence of Substance Use Among Patients of Community Health Centers in East Los Angeles and Tijuana.

Lillian Gelberg, Guillermina Natera Rey, Ronald M Andersen, Miriam Arroyo, Ietza Bojorquez-Chapela, Melvin W Rico, Mani Vahidi, Julia Yacenda-Murphy, Lisa Arangua, Martin Serota

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Substance use & misuse, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04935606 (mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04935606 nacompletednot on this mapstarted 2021, after this paper: background citation

mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care

TypeinterventionalSponsorUniversity of California, Los AngelesRan2021 to 2026Enrolled457ConditionsDrug UseArmsUsual Care, QUIT Intervention (doctor brief advice, video doctor, health coaching sessions at 2- and 6-weeks), QUIT-Mobile (QUIT Intervention plus weekly mobile-web app or text message weekly self-monitoring, automated feedback over 12 months)
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Lillian Gelberga Department of Family Medicine , David Geffen School of Medicine at UCLA , Los Angeles , California , USA.
Guillermina Natera Reyc National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.
Ronald M Andersenb Department of Health Services , UCLA School of Public Health , Los Angeles , California , USA.
Miriam Arroyoc National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.
Ietza Bojorquez-Chapelad Department of Population Studies , El Colegio de la Frontera Norte , Tijuana , Mexico.
Melvin W Ricoa Department of Family Medicine , David Geffen School of Medicine at UCLA , Los Angeles , California , USA.
Mani Vahidia Department of Family Medicine , David Geffen School of Medicine at UCLA , Los Angeles , California , USA.
Julia Yacenda-Murphya Department of Family Medicine , David Geffen School of Medicine at UCLA , Los Angeles , California , USA.
Lisa Aranguaa Department of Family Medicine , David Geffen School of Medicine at UCLA , Los Angeles , California , USA.
Martin Serotae AltaMed Health Services Corporation , Los Angeles , California , USA.
University of California, Los Angeles · USInstituto Nacional de Psiquiatría · MXAltaMed · USEl Colegio de la Frontera Norte · MX

Funding

INNOVATIVE IMPLEMENTATION RESEARCH METHODS COREP30DA027828 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BROWN, C. HENDRICKS, MUSTANSKI, BRIAN · 2011 to 2020
$11.4M
Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African AmericansP30DA027827 · NIDA · UNIVERSITY OF GEORGIA · PI BRODY, GENE H. · 2009 to 2018
$10.2M
NIDA NIH HHS P30 DA027827NIDA NIH HHS P30 DA027828
6 · The paper itself

Abstract

backgroundGiven the increased use of psychoactive substances on the United States-Mexico border, a binational study (Tijuana, Mexico-Los Angeles, USA) was conducted to identify the prevalence of substance use in primary care settings.

objectivesTo compare the prevalence and characteristics of patients at risk for substance use disorders in Tijuana and East Los Angeles (LA) community clinics with special attention paid to drug use.

methodsThis was an observational, cross-sectional, analytical study, comparing substance use screening results from patients in Tijuana and LA. The settings were 2 community clinics in LA and 6 in Tijuana. Participants were 2,507 adult patients in LA and 2,890 in Tijuana eligible for WHO Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) screening during March-October 2013. Patients anonymously self-administered the WHO ASSIST on a tablet PC in the clinic waiting rooms.

resultsOf eligible patients, 96.4% completed the ASSIST in Tijuana and 88.7% in LA (mean 1.34 minutes and 4.20 minutes, respectively). The prevalence of patients with moderate-to-high substance use was higher in LA than Tijuana for each substance: drugs 19.4% vs. 5.7%, alcohol 15.2% vs. 6.5%, tobacco 20.4% vs. 16.2%. LA patients born in Mexico had 2x the odds and LA patients born in the United States had 6x the odds of being a moderate-to-high drug user compared to Tijuana patients born in Mexico.

conclusionsModerate-to-high drug use is higher in LA than in Tijuana but rates are sufficiently high in both to suggest that screening for drug use (along with alcohol and tobacco use) should be integrated into routine primary care of community clinics in both cities.

Indexed as

AdolescentAdultAgedCommunity Health CentersCross-Sectional StudiesFemaleHumansLos AngelesMaleMexicoMiddle AgedPrevalenceSubstance-Related DisordersYoung Adultalcoholcommunity health centersDrugsprimary caretobacco

Identifiers

PMID28001094
PMCPMC6003777
OpenAlexW2561679693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.